In a paper published in Nature Communications, scientists from MedGenome India/USA, along with
Australia is grappling with a pervasive gambling crisis, with gaming
Cipla to price Covid-19 drug ‘Cipremi’ at less than ₹5,000/vial
Mumbai-based drugmaker Cipla on Tuesday said it will price 'Cipremi', its generic version of Gilead's remdesivir for use in Covid-19 patients, at less than
Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease
Cipla Limited (BSE: 500087; NSE: CIPLA EQ, hereinafter referred to as “Cipla”), today announced the launch of remdesivir under its brand name CIPREMI. The
Blood Plasma Therapy Works For COVID-19, Confirms Mayo Study
Blood plasma products manufacturing company urges government to support plasma therapy for COVID care For those worried about using plasma therapy against COVID-19, there's some
Lack of global leadership greatest threat in fighting pandemic: WHO
WHO chief Tedros Ghebreyesus has said the lack of global leadership and unity to fight coronavirus is a bigger threat than the outbreak itself,
Cipla, Glenmark shares hit 52-week high over launch of COVID-19 drugs
Cipla's shares on Monday surged 9.2% to hit a new 52-week high of ₹696 on BSE. This comes after it was allowed to manufacture
India records nearly 11,000 coronavirus recoveries in last 24 hours
As many as 10,994 coronavirus recoveries were recorded in India in the last 24 hours, taking the total number of patients who have been
Give details of every COVID-19 death to us: Centre to Delhi govt
The Ministry of Home Affairs (MHA) on Sunday asked the Delhi government to delineate all containment zones afresh and enumerate all households even outside
BMC to increase bed capacity to 1L by June-end in Mumbai
BMC Municipal commissioner IS Chahal said that BMC will increase bed capacity in Mumbai from the current 84,000 to 1 lakh by June-end for